Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
作者信息
Leegte B, van der Hout A H, Deffenbaugh A M, Bakker M K, Mulder I M, ten Berge A, Leenders E P, Wesseling J, de Hullu J, Hoogerbrugge N, Ligtenberg M J L, Ardern-Jones A, Bancroft E, Salmon A, Barwell J, Eeles R, Oosterwijk J C
机构信息
Department of Clinical Genetics, Groningen University Medical Centre, Groningen, The Netherlands.
出版信息
J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243.
Abstract
摘要
相似文献
1
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243.
2
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.
Breast Cancer Res Treat. 2005 May;91(2):203-5. doi: 10.1007/s10549-004-7704-4.
3
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9.
4
Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.
Cancer Res. 2002 May 15;62(10):2741-3.
5
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536.
6
Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon?
Breast Cancer Res Treat. 2005 Aug;92(3):273-7. doi: 10.1007/s10549-005-3377-x.
7
Genomic rearrangements in the BRCA1 and BRCA2 genes.
Hum Mutat. 2005 May;25(5):415-22. doi: 10.1002/humu.20169.
8
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039.
9
Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Neoplasma. 2006;53(2):97-102.
10
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27.
引用本文的文献
1
Clinicopathological features of Chinese ovarian cancer patients with double heterozygosity for cancer-predisposed genes.
BMC Cancer. 2025 Aug 28;25(1):1391. doi: 10.1186/s12885-025-14835-0.
2
Case Report: Clinical impact of and vs. and germline double heterozygosity in ovarian cancer: a comparative case study.
Front Oncol. 2025 Jul 24;15:1614373. doi: 10.3389/fonc.2025.1614373. eCollection 2025.
3
Double heterozygosity for and in breast cancer: considerations in surveillance and cancer risk management.
BMJ Case Rep. 2025 Apr 22;18(4):e263687. doi: 10.1136/bcr-2024-263687.
4
Multi-locus inherited neoplasia alleles syndromes in cancer: implications for clinical practice.
Eur J Hum Genet. 2025 Mar;33(3):289-296. doi: 10.1038/s41431-025-01785-1. Epub 2025 Jan 23.
5
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients.
Cancers (Basel). 2024 Jul 15;16(14):2547. doi: 10.3390/cancers16142547.
6
Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants.
Breast Cancer Res Treat. 2024 Nov;208(1):155-164. doi: 10.1007/s10549-024-07409-4. Epub 2024 Jun 20.
7
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.
Breast Cancer Res Treat. 2024 Feb;204(1):171-179. doi: 10.1007/s10549-023-07176-8. Epub 2023 Dec 13.
8
Double Heterozygosity for Rare Deleterious Variants in the and Genes in a Hungarian Patient with Breast Cancer.
Int J Mol Sci. 2023 Oct 18;24(20):15334. doi: 10.3390/ijms242015334.
9
Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
BMC Cancer. 2022 Feb 25;22(1):208. doi: 10.1186/s12885-022-09181-4.
10
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both and .
Case Rep Oncol. 2021 Nov 18;14(3):1645-1651. doi: 10.1159/000520148. eCollection 2021 Sep-Dec.
Zotero 插件